The Rise of the GILD Stock
Have you ever heard of gild stock? This stands for the ticker symbol GILD, and the stock is currently one of the hottest stocks on the market. The stock is traded on the NASDAQ, and it represents ownership in Gilead Sciences, which is a pharmaceutical company.
Just five years ago you could buy stocks in the company for less than $20 dollars a pop. Can you guess how much the company’s stocks are selling for right now? You’re going to have to shell out $80 bucks for just a single share. This means if you have invested in GILD a few years ago, you would have been able to quadruple your wealth (yes, you read that right: quadruple). If you had invested $10,000 dollars five years ago, you’d now have more than $40,000 dollars!
These are the types of returns investors dream of. It doesn’t matter if you’re Warren Buffet, George Soros, or a retiree trying to save up for the golden years, these types of returns are quite simply envious. A few years back, you could have made even more money because GILD had actually peaked at about $120 dollars. Could you imagine those types of returns? Few companies are ever able to provide that type of income off of stocks for their investors.
Investing in the Future of Health
While Gild sciences has cooled off, this doesn’t mean that the company is on the decline. Fact is, the company is still a hot name in the pharma industry. Gilead is well known for its HIV drugs, as well as treatments for blood cancers and other diseases. The company also sells drugs for influenza, hepatitis b and hepatitis C, and various other illnesses. Honestly, describing the company’s products requires a bit of a medical tongue that you may not be familiar with, but let’s just say that the company is on the cutting edge of pharmaceuticals. For investors, that is certainly good news.
So far, the company and its executive team has proven to be quiet savvy in the acquisitions market. Buying up smaller companies is essential for big pharma because that’s how many of them acquire their research. Why should a company bother investing millions into research that may or may not pan out when they can just buy up a smaller company that has already made some major breakthroughs?
For investors, this acquisition track record is vital because it will add value to stocks over the long haul. So long as the company makes savvy purchases, this will provide some upwards momentum for stock prices. While acquisitions alone may not prop up prices, they certainly are a good start. It’s also something that investors should pay especially close attention to.
Trading GILD Stocks
Since GILD is sold on the NASDAQ, just about every broker will be able to provide you with stock from the company. If you are looking to invest, it’s just a simple matter of setting up an account and buying the stock.
Not only is GILD a stock with upside, the company also pays dividends. While these dividends usually amount to less than 50 cents a share per quarter, over time this money can really add up. We love dividend stocks because they provide stable income and are a great option for people on a fixed income.
High-Risk, High-Reward Investment
We recommend you keep a close eye on gild stock news going forward. On the whole, the stock looks pretty strong, and with a marketcap of “only” $130 billion dollars, there is still room for the company to grow. As always, however, we need to be up front with our warnings. Biotech stocks are often higher risk, higher reward investment opportunities.
This is true even for big blue chip companies, like Gilead Sciences or Pfizer. If a drug trial proves promising, or a major breakthrough is made, stocks can soar. On the other hand if there are unexpected complications or a drug fails its tests, stocks can be leveled overnight. So when you invest in Gilead or any other pharma company, make sure you take all of the risks into account.
Sometimes, people will misspell the stock ticker and say “sild stock price” instead. “S” isn’t that close to “g” on the keyboard, but this typo is common enough. Also, you’ll see a lot of people type in gold tock quote. This time around they simply forgot the S. Regardless, these investors are searching for Gilead Sciences, with the ticker GILD.
Either way, we recommend that you keep a close eye on GILD. No, we wouldn’t recommend you betting the house or your kid’s college fund on this stock, but we wouldn’t recommend you do that for any stock. If you are interested in a blue chip pharma company that pays out decent dividends, however, GILD should make your shortlist.
So make sure you do some research on GILD and determine if this stock is the right addition for your stock portfolio!